The market performance of Kiniksa Pharmaceuticals International Plc has been somewhat stable. Over the past year, the company’s stock achieved a high of $28.15 on 10/28/24, with the lowest value for the same timeframe being $16.56, recorded on 04/19/24.
52-week price history of KNSA Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Kiniksa Pharmaceuticals International Plc’s current trading price is -15.42% away from its 52-week high, while its distance from the 52-week low is 43.78%. The stock’s price range during this period has fluctuated between $16.56 and $28.15. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.59 million for the day, which was evidently lower than the average daily volume of 0.6 million over the last three months.
Financial Performance and Market Capitalization
Kiniksa Pharmaceuticals International Plc (KNSA) has experienced a quarterly rise of 17.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.73B and boasts a workforce of 315 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.98, with a change in price of -3.03. Similarly, Kiniksa Pharmaceuticals International Plc recorded 485,392 in trading volume during the last 100 days, posting a change of -11.29%.
KNSA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for KNSA stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
KNSA Stock Stochastic Average
The raw stochastic average for Kiniksa Pharmaceuticals International Plc over the last 50 days is presently at 92.30%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 90.22%. Further, the company’s Stochastic %K and %D values for the last 20 days were 92.06% and 92.52%, respectively.
KNSA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 20.37% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -6.22%. Over the past 30 days, the price of KNSA has fallen by 20.74%. And in the last five days, it has surged by 7.45%.
